Eli Lilly

Mounjaro (Tirzepatide)

1,198.80 SR

Control blood sugar levels and reduce appetite.

Tirzepatide, the active ingredient in Mounjaro, works by mimicking the effects of natural hormones in the body that regulate blood sugar levels and appetite. As a dual agonist of GIP (glucose-dependent insulinotropic peptide) and GLP-1 (glucagon-like peptide-1) receptors, it enhances insulin secretion in response to high blood sugar levels, slows gastric emptying, and reduces appetite and food intake, leading to improved blood sugar control and weight loss in adults with type 2 diabetes.

Identity verification is required to purchase this medicine.

Identity verification is required to fill a prescription.

Guarantees

Same day dispatch to ensure prompt treatment.
Confidential and confidential service.
Professional medical advice.
Effective and prompt support for inquiries.

The injection pen contains four doses, to be taken once a week.: 2.5 MG

2.5 MG
5 MG
7.5 MG
10 MG
12.5 MG
15 MG

Product variants

In stock

Pickup available at Head Office

Usually ready in 1 hour

Share:

Share

Need help?

Pairs well with

Start with medical advice

To get started, please return to the Patient Profile page.

Start Consultation

Quick summary

Type of medication

Dual agonist of GIP and GLP-1 receptors.

Manufacturer

Eli Lilly

Active ingredient

Tirzepatide, the active ingredient in Mounjaro, works by mimicking the effects of natural hormones in the body that regulate blood sugar and appetite. As a dual agonist of GIP (glucose-dependent insulinotropic peptide) and GLP-1 (glucagon-like peptide-1) receptors, it enhances insulin secretion in response to high blood sugar levels, slows gastric emptying, and reduces appetite and food intake, leading to improved blood sugar control and weight loss in adults with type 2 diabetes.

Effective during

In a few weeks.

Mechanism of action

Control blood sugar levels and reduce appetite.

Side effects

Gastrointestinal problems (nausea, vomiting, diarrhea, constipation), possible low blood sugar (especially when used with other diabetes medications), reactions at the injection site, and possibly others depending on the individual's health condition and other medications being taken.

DHL Express shipping within 2 to 5 days

Drug details

Description and method of use

Mounjaro is initiated at a dose of 2.5 mg (0.6 ml) by subcutaneous injection once weekly for 4 weeks, increasing the dose by 2.5 mg every 4 weeks to a maximum of 15 mg, with treatment evaluated after 24 weeks for effectiveness. Injections are given in the abdomen, thigh or upper arm, rotating sites to avoid complications.

Store Monjaro in the refrigerator (2-8°C). Do not freeze. Not for use by children under 18 years of age, pregnant or breast-feeding women, and use with caution if you have a history of pancreatitis or severe intestinal problems. Use as directed by your healthcare professional. Read the package leaflet before use.

the components

Tirzepatide, the active ingredient in Mounjaro, works by mimicking the effects of natural hormones in the body that regulate blood sugar levels and appetite. As a dual agonist of GIP (glucose-dependent insulinotropic peptide) and GLP-1 (glucagon-like peptide-1) receptors, it enhances insulin secretion in response to high blood sugar levels, slows gastric emptying, and reduces appetite and food intake, leading to improved blood sugar control and weight loss in adults with type 2 diabetes.

Side effects

Gastrointestinal problems (nausea, vomiting, diarrhea, constipation), possible low blood sugar (especially when used with other diabetes medications), reactions at the injection site, and possibly others depending on the individual's health condition and other medications being taken.

Warnings

When using Mounjaro (tirzepatide), important precautions include being alert for severe abdominal pain that could be a sign of pancreatitis, monitoring your blood sugar levels due to the risk of low blood sugar when used with other diabetes medications, reporting any changes in urination that could indicate kidney problems, and seeking immediate medical attention if you have persistent digestive problems such as vomiting or diarrhea. It is also important to tell your doctor about any personal or family history of thyroid cancer, given studies linking medications similar to Mounjaro to thyroid problems in rodents. Be alert for signs of allergic reactions, and if you are pregnant or breastfeeding, talk to your healthcare provider about the potential risks.

Frequently Asked Questions

Please read our FAQ page to learn more.

How long does it take for Monjaro to start working?

The onset of effects of Mounjaro may vary, but patients may begin to see improvements in blood sugar levels and weight within a few weeks of starting treatment. Continued use in conjunction with diet and exercise increases its effectiveness.

Do I need a prescription for Monjaro?

Yes, Mounjaro is a prescription medication. You will need to consult with your healthcare provider to determine if it is appropriate for your condition and to obtain a prescription. Using our online consultation service will allow you to answer a short questionnaire that will be used by one of our medical recommenders to determine your eligibility for treatment, approve or decline it, and return your order.

How is Monjaro given?

Mounjaro is given as an injection under the skin once a week. It can be injected into the abdomen, thigh, or upper arm, with the injection site rotated each week to reduce the risk of skin irritation.